Inactive Instrument
Aoxing Pharmaceutical Company, Inc. Stock Other OTC
Stocks
AOXG
US03740A1060
Professional & Business Education
OTC Markets Traded| Market Cap | 23.62M 20.66M 19.06M 17.56M 33.12M 2.27B 33.85M 228M 89.5M 1.11B 88.72M 86.76M 3.84B | P/E 2015 |
20.1x | P/E 2016 | 23.2x |
|---|---|---|---|---|---|
| Enterprise Value | 42.18M 36.88M 34.04M 31.36M 59.14M 4.06B 60.44M 407M 160M 1.99B 158M 155M 6.85B | EV / Sales 2015 |
5.77x | EV / Sales 2016 | 2.11x |
| Free-Float |
100% | Yield 2015 * |
-
| Yield 2016 | - |
| 1 day | -20.71% |
| Manager | Title | Age | Since |
|---|---|---|---|
Chun Fai Lo
CEO | Chief Executive Officer | - | - |
Po Chim
DFI | Director of Finance/CFO | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -20.71% | -19.80% | - | - | 1.33M | |
| -0.64% | -16.80% | +23.92% | +485.05% | 2.22B | |
| -3.47% | -4.53% | - | - | 1.89B | |
| -2.72% | -5.79% | -41.12% | -61.42% | 1.63B | |
| -2.53% | -20.81% | +86.90% | +581.75% | 1.36B | |
| -0.46% | +3.12% | -40.77% | +38.26% | 1.22B | |
| +0.49% | +0.24% | +311.20% | +921.00% | 1.1B | |
| -0.75% | -0.79% | +48.28% | +26.95% | 932M | |
| +10.06% | -13.33% | +33.68% | +46.57% | 776M | |
| -2.22% | -4.35% | -41.02% | -90.30% | 428M | |
| Average | -2.30% | -5.62% | +47.63% | +243.48% | 1.28B | |
| Weighted average by Cap. | -0.84% | -6.73% | +46.70% | +295.19% |
| 2015 | 2016 | |
|---|---|---|
| Net sales | 25.48M 22.28M 20.56M 18.94M 35.72M 2.45B 36.51M 246M 96.53M 1.2B 95.69M 93.58M 4.14B | 32.33M 28.27M 26.09M 24.03M 45.33M 3.11B 46.32M 312M 122M 1.52B 121M 119M 5.25B |
| Net income | 5.49M 4.8M 4.43M 4.08M 7.7M 529M 7.87M 53M 20.82M 259M 20.63M 20.18M 892M | 2.06M 1.8M 1.66M 1.53M 2.89M 198M 2.95M 19.88M 7.81M 97.16M 7.74M 7.57M 335M |
| Net Debt | 24.8M 21.69M 20.02M 18.44M 34.78M 2.39B 35.54M 239M 93.97M 1.17B 93.15M 91.1M 4.03B | 18.56M 16.23M 14.98M 13.8M 26.02M 1.79B 26.59M 179M 70.31M 875M 69.7M 68.16M 3.01B |
Employees
-
Choose MarketScreener 
